Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract LB062: Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma

Cancer Res (2021) 81 (13_Supplement): LB062.

https://doi.org/10.1158/1538-7445.AM2021-LB062

Published: 01 July 2021

View article titled, Abstract LB062: Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma

Journal Articles

Abstract LB227: Automated image registration and alignment facilitates assessment of change in pigmented lesions of patients at risk for melanoma

William F. Maguire, Paul H. Haley, Catherine M. Dietz, Mike Hoffelder, Clara S. Brandt, Robin Joyce, Melissa D. Wilson, Darcy Ploucha, Christopher Minnier, Cindy Sander, Hong Wang, Hassane M. Zarour, Kevin J. Mitchell, Ellen K. Hughes, John M. Kirkwood

Cancer Res (2021) 81 (13_Supplement): LB227.

https://doi.org/10.1158/1538-7445.AM2021-LB227

Published: 01 July 2021

View article titled, Abstract LB227: Automated image registration and alignment facilitates assessment of change in pigmented lesions of patients at risk for melanoma

Journal Articles

Abstract 4046: Interleukin-10 and programmed death-1 cooperate to regulate tumor antigen-specific CD8+ T cells in melanoma patients

Zhaojun Sun, Julien Fourcade, Ornella Pagliano, Joe-Marc Chauvin, Cindy Sander, John M. Kirkwood, Hassane M. Zarour

Cancer Res (2015) 75 (15_Supplement): 4046.

https://doi.org/10.1158/1538-7445.AM2015-4046

Published: 01 August 2015

View article titled, Abstract 4046: Interleukin-10 and programmed death-1 cooperate to regulate tumor antigen-specific CD8+ T cells in melanoma patients

Journal Articles

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8⁺ T Cells

Zhaojun Sun, Julien Fourcade, Ornella Pagliano, Joe-Marc Chauvin, Cindy Sander, John M. Kirkwood, Hassane M. Zarour

Cancer Res (2015) 75 (8): 1635–1644.

https://doi.org/10.1158/0008-5472.CAN-14-3016

Published: 14 April 2015

View article titled, IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells

Includes: Supplementary data

Journal Articles

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8⁺ T Cells Induced by Melanoma Vaccines

Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Joe-Marc Chauvin, Cindy Sander, Bratislav Janjic, Ahmad A. Tarhini, Hussein A. Tawbi, John M. Kirkwood, Stergios Moschos, Hong Wang, Philippe Guillaume, Immanuel F. Luescher, Arthur Krieg, Ana C. Anderson, Vijay K. Kuchroo, Hassane M. Zarour

Cancer Res (2014) 74 (4): 1045–1055.

https://doi.org/10.1158/0008-5472.CAN-13-2908

Published: 16 February 2014

View article titled, PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8+ T Cells Induced by Melanoma Vaccines

Includes: Supplementary data

Journal Articles

Abstract 4576: Immunization with CPG in combination with MHC class I and class II peptides stimulates rapid and strong tumor antigen-specific CTL responses in melanoma patients.

Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Joe-Marc Chauvin, Cindy Sander, Stergios Moschos, Ahmad Tarhini, Hussein Tawbi, John M. Kirkwood, Hassane M. Zarour

Cancer Res (2013) 73 (8_Supplement): 4576.

https://doi.org/10.1158/1538-7445.AM2013-4576

Published: 15 April 2013

View article titled, Abstract 4576: Immunization with CPG in combination with MHC class I and class II peptides stimulates rapid and strong tumor antigen-specific CTL responses in melanoma patients.

Journal Articles

Abstract 5407: The upregulation of BTLA and PD-1 defines a novel subset of dysfunctional tumor antigen-specific CD8+ T cells

Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Daniel Olive, Vijay Kuchroo, Hassane M. Zarour

Cancer Res (2012) 72 (8_Supplement): 5407.

https://doi.org/10.1158/1538-7445.AM2012-5407

Published: 15 April 2012

View article titled, Abstract 5407: The upregulation of BTLA and PD-1 defines a novel subset of dysfunctional tumor antigen-specific CD8+ T cells

Journal Articles

CD8⁺ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Julien Fourcade, Zhaojun Sun, Ornella Pagliano, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Daniel Olive, Vijay Kuchroo, Hassane M. Zarour

Cancer Res (2012) 72 (4): 887–896.

https://doi.org/10.1158/0008-5472.CAN-11-2637

Published: 14 February 2012

View article titled, CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Includes: Supplementary data

Journal Articles

Abstract 3657: Upregulation of PD-1 and Tim-3 expression on tumor antigen-specific CD4+ T cells is associated with reversible T cell dysfunction in patients with advanced melanoma

Julien Fourcade, Zhaojun Sun, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Vijay Kuchroo, Hassane M. Zarour

Cancer Res (2011) 71 (8_Supplement): 3657.

https://doi.org/10.1158/1538-7445.AM2011-3657

Published: 15 April 2011

View article titled, Abstract 3657: Upregulation of PD-1 and Tim-3 expression on tumor antigen-specific CD4+ T cells is associated with reversible T cell dysfunction in patients with advanced melanoma

Journal Articles

Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8⁺ and CD4⁺ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling

Tatiana Raskovalova, Anna Lokshin, Xiaojun Huang, Yunyun Su, Maja Mandic, Hassane M. Zarour, Edwin K. Jackson, Elieser Gorelik

Cancer Res (2007) 67 (12): 5949–5956.

https://doi.org/10.1158/0008-5472.CAN-06-4249

Published: 15 June 2007

View article titled, Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8+ and CD4+ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling

Journal Articles

Spontaneous CD4+ regulatory T cell responses against TRAG-3 in patients with melanoma and breast cancers

Bratislav Janjic, Pavol Kudela, Pedro Andrade, Adam Brufsky, Samuel Jacobs, David Friedland, Daniel Gillet, Ronald B. Herberman, John M. Kirkwood, Bernard Maillere, Hassane M. Zarour

Cancer Res (2006) 66 (8_Supplement): 527.

Published: 15 April 2006

View article titled, Spontaneous CD4+ regulatory T cell responses against TRAG-3 in patients with melanoma and breast cancers

Journal Articles

Two universal NY-ESO-1/LAGE-1-derived epitopes promiscuously bind to multiple HLA-DR and HLA-DPB1*0401 molecules and stimulate autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma

Maja Mandic, Florence Castelli, Bratislav Janjic, Christine Almunia, Pedro Andrade, Daniel Gillet, Vladimir Brusic, John Kirkwood, Bernard Maillere, Hassane M. Zarour

Cancer Res (2004) 64 (7_Supplement): 290.

Published: 01 April 2004

View article titled, Two universal NY-ESO-1/LAGE-1-derived epitopes promiscuously bind to multiple HLA-DR and HLA-DPB1*0401 molecules and stimulate autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma

Journal Articles

The Alternative Open Reading Frame of LAGE-1 Gives Rise to Multiple Promiscuous HLA-DR-restricted Epitopes Recognized by T-helper 1-type Tumor-reactive CD4+ T Cells

Maja Mandic, Christine Almunia, Stephanie Vicel, Daniel Gillet, Bratislav Janjic, Kara Coval, Bernard Maillere, John M. Kirkwood, Hassane M. Zarour

Cancer Res (2003) 63 (19): 6506–6515.

Published: 14 October 2003

View article titled, The Alternative Open Reading Frame of LAGE-1 Gives Rise to Multiple Promiscuous HLA-DR-restricted Epitopes Recognized by T-helper 1-type Tumor-reactive CD4+ T Cells

Journal Articles

NY-ESO-1 119–143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells

Hassane M. Zarour, Bernard Maillere, Vladimir Brusic, Kara Coval, Eileen Williams, Sandra Pouvelle-Moratille, Florence Castelli, Stephanie Land, Jaafar Bennouna, Theodore Logan, John M. Kirkwood

Cancer Res (2002) 62 (1): 213–218.

Published: 01 January 2002

View article titled, NY-ESO-1 119–143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells

Journal Articles

NY-ESO-1 Encodes DRB1*0401-restricted Epitopes Recognized by Melanoma-reactive CD4+ T Cells

Hassane M. Zarour, Walter J. Storkus, Vladimir Brusic, Eileen Williams, John M. Kirkwood

Cancer Res (2000) 60 (17): 4946–4952.

Published: 01 September 2000

View article titled, NY-ESO-1 Encodes DRB1*0401-restricted Epitopes Recognized by Melanoma-reactive CD4+ T Cells

NARROW

Abstract LB062: Efficacy of Responder-derived Fecal Microbiota Transplant (R-FMT) and Pembrolizumab in Anti-PD-1 Refractory Patients with Advanced Melanoma

Abstract LB227: Automated image registration and alignment facilitates assessment of change in pigmented lesions of patients at risk for melanoma

Abstract 4046: Interleukin-10 and programmed death-1 cooperate to regulate tumor antigen-specific CD8+ T cells in melanoma patients

IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8⁺ T Cells

PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen–Specific CD8⁺ T Cells Induced by Melanoma Vaccines

Abstract 4576: Immunization with CPG in combination with MHC class I and class II peptides stimulates rapid and strong tumor antigen-specific CTL responses in melanoma patients.

Abstract 5407: The upregulation of BTLA and PD-1 defines a novel subset of dysfunctional tumor antigen-specific CD8+ T cells

CD8⁺ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1

Abstract 3657: Upregulation of PD-1 and Tim-3 expression on tumor antigen-specific CD4+ T cells is associated with reversible T cell dysfunction in patients with advanced melanoma

Inhibition of Cytokine Production and Cytotoxic Activity of Human Antimelanoma Specific CD8⁺ and CD4⁺ T Lymphocytes by Adenosine-Protein Kinase A Type I Signaling

Spontaneous CD4+ regulatory T cell responses against TRAG-3 in patients with melanoma and breast cancers

Two universal NY-ESO-1/LAGE-1-derived epitopes promiscuously bind to multiple HLA-DR and HLA-DPB1*0401 molecules and stimulate autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma

The Alternative Open Reading Frame of LAGE-1 Gives Rise to Multiple Promiscuous HLA-DR-restricted Epitopes Recognized by T-helper 1-type Tumor-reactive CD4+ T Cells

NY-ESO-1 119–143 Is a Promiscuous Major Histocompatibility Complex Class II T-Helper Epitope Recognized by Th1- and Th2-Type Tumor-reactive CD4+ T Cells

NY-ESO-1 Encodes DRB1*0401-restricted Epitopes Recognized by Melanoma-reactive CD4+ T Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only